BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7331055)

  • 1. Genetic predisposition to renal stone disease in the first-degree relatives of stone-formers.
    Marya RK; Dadoo RC; Sharma NK
    Urol Int; 1981; 36(4):245-7. PubMed ID: 7331055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of urinary calcium excretion after oral calcium load in stone formers, their spouses and first-degree blood relatives.
    Kaul P; Sidhu H; Vaidyanathan S; Thind SK; Nath R
    Urol Int; 1994; 52(2):93-7. PubMed ID: 8178384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of calcium oxalate crystalluria on renal and vesical urines in stone formers and normal subjects.
    Robert M; Boularan AM; Delbos O; Guiter J; Descomps B
    Urol Int; 1998; 60(1):41-6. PubMed ID: 9519420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of hyperoxaluria in idiopathic calcium oxalate kidney stone disease.
    Baggio B; Gambaro G; Favaro S; Borsatti A
    Nephron; 1983; 35(1):11-4. PubMed ID: 6888620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial crystalluria determination and the risk of recurrence in calcium stone formers.
    Daudon M; Hennequin C; Boujelben G; Lacour B; Jungers P
    Kidney Int; 2005 May; 67(5):1934-43. PubMed ID: 15840041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulatory effect of the 23-kD calcium oxalate monohydrate binding protein on calcium oxalate stone formation during oxalate stress.
    Asokan D; Kalaiselvi P; Varalakshmi P
    Nephron Physiol; 2004; 97(1):p23-30. PubMed ID: 15153748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of gender and age on calcium oxalate crystal growth inhibition by urine from relatives of stone forming patients.
    Bergsland KJ; Kinder JM; Asplin JR; Coe BJ; Coe FL
    J Urol; 2002 Jun; 167(6):2372-6. PubMed ID: 11992040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystalluria in normal subjects and in stone formers with and without thiazide and cellulose phosphate treatment.
    Hallson PC; Rose GA
    Br J Urol; 1976; 48(7):515-24. PubMed ID: 13904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
    Hess B
    Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystallization properties in urine from calcium oxalate stone formers.
    Tiselius HG; Bek-Jensen H; Fornander AM; Nilsson MA
    J Urol; 1995 Sep; 154(3):940-6. PubMed ID: 7637098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium oxalate crystalluria and inhibitors of crystallization in recurrent renal stone-formers.
    Robertson WG; Peacock M
    Clin Sci; 1972 Oct; 43(4):499-506. PubMed ID: 4653589
    [No Abstract]   [Full Text] [Related]  

  • 12. Calcium-binding proteins and renal lithiasis.
    Resnick MI; Gammon CW; Sorrell MB; Boyce WH
    Surgery; 1980 Aug; 88(2):239-43. PubMed ID: 7394705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circadian periodicity of urinary inhibitor of calcium oxalate crystallization in healthy Indians and renal stone formers.
    Singh RK; Bansal A; Bansal SK; Singh AK; Mahdi AA
    Eur Urol; 1993; 24(3):387-92. PubMed ID: 8262108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleation of calcium oxalate crystals by albumin: involvement in the prevention of stone formation.
    Cerini C; Geider S; Dussol B; Hennequin C; Daudon M; Veesler S; Nitsche S; Boistelle R; Berthézène P; Dupuy P; Vazi A; Berland Y; Dagorn JC; Verdier JM
    Kidney Int; 1999 May; 55(5):1776-86. PubMed ID: 10231440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal intratubular crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones.
    Evan AP; Coe FL; Gillen D; Lingeman JE; Bledsoe S; Worcester EM
    Anat Rec (Hoboken); 2008 Mar; 291(3):325-34. PubMed ID: 18286613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation by macromolecules of calcium oxalate crystal aggregation in stone formers.
    Wesson JA; Ganne V; Beshensky AM; Kleinman JG
    Urol Res; 2005 Jun; 33(3):206-12. PubMed ID: 15864572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of urine dilution on quantity, size and aggregation of calcium oxalate crystals induced in vitro by an oxalate load.
    Guerra A; Allegri F; Meschi T; Adorni G; Prati B; Nouvenne A; Novarini A; Maggiore U; Fiaccadori E; Borghi L
    Clin Chem Lab Med; 2005; 43(6):585-9. PubMed ID: 16006253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of renal phosphate leak among patients with calcium nephrolithiasis.
    Prié D; Ravery V; Boccon-Gibod L; Friedlander G
    Kidney Int; 2001 Jul; 60(1):272-6. PubMed ID: 11422761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium oxalate monohydrate binding protein: a diagnostic biomarker for calcium oxalate kidney stone formers.
    Asokan D; Kalaiselvi P; Muhammed Farooq S; Varalakshmi P
    Urol Res; 2004 Oct; 32(5):357-61. PubMed ID: 15365653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial forms of hypercalciuria.
    Favus MJ
    J Urol; 1989 Mar; 141(3 Pt 2):719-22. PubMed ID: 2645430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.